Review: taking Ranitidine hydrochloride and Dexamethasone sodium phosphate together


Summary

Drug interactions are reported among people who take Ranitidine hydrochloride and Dexamethasone sodium phosphate together. This review analyzes the effectiveness and drug interactions between Ranitidine hydrochloride and Dexamethasone sodium phosphate. It is created by eHealthMe based on reports of 1,747 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Ranitidine Hydrochloride

Ranitidine hydrochloride has active ingredients of ranitidine hydrochloride. It is often used in indigestion. (latest outcomes from Ranitidine hydrochloride 6,145 users)

Dexamethasone Sodium Phosphate

Dexamethasone sodium phosphate has active ingredients of dexamethasone sodium phosphate. It is often used in multiple myeloma. (latest outcomes from Dexamethasone sodium phosphate 3,944 users)

On Sep, 24, 2016

1,747 people who take Ranitidine Hydrochloride, Dexamethasone Sodium Phosphate are studied.


Number of reports submitted per year:

Ranitidine hydrochloride and Dexamethasone sodium phosphate drug interactions.

Most common drug interactions over time *:

< 1 month:
  • neutropenia
  • febrile neutropenia
  • nausea
  • vomiting
  • dyspnoea
  • proteinuria
  • pneumonia
  • death
  • deep vein thrombosis
  • erythema
1 - 6 months:
  • white blood cell count decreased
  • interstitial lung disease
  • dehydration
  • malignant neoplasm progression
  • pneumonia
  • neutropenia
  • neutrophil count decreased
  • stomatitis
  • hypertension
  • febrile neutropenia
6 - 12 months:
  • osteonecrosis
  • tooth extraction
  • diarrhoea
  • nausea
  • neutropenia
  • pyrexia
  • abdominal pain upper
  • asthenia
  • constipation
  • death
1 - 2 years:
  • femur fracture
  • anaemia
  • dehydration
  • gastrointestinal haemorrhage
  • hypercalcaemia
  • lower respiratory tract infection
  • meningitis streptococcal
  • neutropenic sepsis
  • pyrexia
  • bronchial hyperreactivity
2 - 5 years:
  • intestinal obstruction
  • acute pulmonary oedema
  • chest discomfort
  • chest pain
  • dyspnoea
  • hypertension
  • hypotension
  • urinary tract infection
5 - 10 years:
  • complex partial seizures
not specified:
  • fatigue
  • nausea
  • death
  • dyspnoea
  • diarrhoea
  • vomiting
  • pyrexia
  • neuropathy peripheral
  • rash
  • thrombocytopenia

Most common drug interactions by gender *:

female:
  • neutropenia
  • nausea
  • fatigue
  • dyspnoea
  • febrile neutropenia
  • vomiting
  • death
  • diarrhoea
  • pyrexia
  • erythema
male:
  • death
  • fatigue
  • pneumonia
  • febrile neutropenia
  • pyrexia
  • nausea
  • diarrhoea
  • vomiting
  • platelet count decreased
  • dyspnoea

Most common drug interactions by age *:

0-1:
  • rib fracture
  • foetal exposure during pregnancy
  • haemolytic anaemia
  • atrial septal defect
  • dermatitis diaper
  • diverticular hernia
  • hyperglycaemia
  • hyponatraemia
  • intestinal ischaemia
  • intestinal perforation
2-9:
  • febrile neutropenia
  • hypersensitivity
  • mucosal inflammation
  • eyelid ptosis
  • conjunctivitis
  • alanine aminotransferase increased
  • aspartate aminotransferase increased
  • neutropenia
  • respiratory distress
  • alopecia
10-19:
  • platelet count decreased
  • stomatitis
  • constipation
  • febrile neutropenia
  • pyrexia
  • disease progression
  • gastrooesophageal reflux disease
  • nausea
  • vomiting
  • white blood cell count decreased
20-29:
  • hyperglycaemia
  • hyponatraemia
  • partial seizures
  • diarrhoea
  • headache
  • osteonecrosis
  • tooth extraction
  • acne
  • alopecia
  • blister
30-39:
  • febrile neutropenia
  • dyspnoea
  • cardiac arrest
  • hypokalaemia
  • diarrhoea
  • fatigue
  • vomiting
  • hypocalcaemia
  • ileus
  • multi-organ failure
40-49:
  • neutropenia
  • dyspnoea
  • nausea
  • fatigue
  • back pain
  • hypertension
  • pain
  • vomiting
  • asphyxia
  • pneumonia
50-59:
  • neutropenia
  • febrile neutropenia
  • nausea
  • fatigue
  • dyspnoea
  • thrombocytopenia
  • vomiting
  • deep vein thrombosis
  • death
  • anaemia
60+:
  • febrile neutropenia
  • nausea
  • fatigue
  • pneumonia
  • diarrhoea
  • vomiting
  • dyspnoea
  • pyrexia
  • anaemia
  • neutropenia

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Ranitidine hydrochloride and Dexamethasone sodium phosphate?

Can you answer these questions?

More questions for: Ranitidine hydrochloride, Dexamethasone sodium phosphate

You may be interested in these reviews

More reviews for: Ranitidine hydrochloride, Dexamethasone sodium phosphate

On eHealthMe, Ranitidine hydrochloride (ranitidine hydrochloride) is often used to treat indigestion. Dexamethasone sodium phosphate (dexamethasone sodium phosphate) is often used to treat multiple myeloma. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.